Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
3.570
+0.050 (1.42%)
At close: Sep 30, 2026, 4:00 PM EDT
3.500
-0.070 (-1.96%)
After-hours: Sep 30, 2026, 5:18 PM EDT
Foghorn Therapeutics Employees
Foghorn Therapeutics had 106 employees as of December 31, 2025. The number of employees decreased by 6 or -5.36% compared to the previous year.
Employees
106
Change (1Y)
-6
Growth (1Y)
-5.36%
Revenue / Employee
$346,594
Profits / Employee
-$609,236
Market Cap
212.01M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | -6 | -5.36% |
| Dec 31, 2024 | 112 | -4 | -3.45% |
| Dec 31, 2023 | 116 | -45 | -27.95% |
| Dec 31, 2022 | 161 | 42 | 35.29% |
| Dec 31, 2021 | 119 | 24 | 25.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Adagene | 128 |
| Alector | 103 |
| Compugen | 75 |
| Cartesian Therapeutics | 75 |
| Compass Therapeutics | 39 |
| Anavex Life Sciences | 34 |
| Eledon Pharmaceuticals | 33 |
FHTX News
- 7 weeks ago - Foghorn Therapeutics reports Q2 EPS (10c), consensus (23c) - TheFly
- 7 weeks ago - Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update - GlobeNewsWire
- 7 weeks ago - Foghorn Therapeutics Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Foghorn Therapeutics Earnings release: Q2 2026 - Filings
- 7 weeks ago - Foghorn Therapeutics Slides: Investor presentation - Filings
- 3 months ago - Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director - GlobeNewsWire
- 3 months ago - Foghorn Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 - GlobeNewsWire